Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians

• Rahul Banerjee,
• Bo Wang,
• Larry D. Anderson,
• Georgia McCaughan,
• Nikita Mehra,
• Andrew J. Cowan,
• S. Vincent Rajkumar,
• Gurbakhash Kaur

Affiliations

Rahul Banerjee

Department of Medicine, University of Washington

Bo Wang

Willamette Valley Cancer Institute

Larry D. Anderson

Myeloma, Waldenstrom’s, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center

Georgia McCaughan

Department of Haematology, St Vincent’s Hospital

Nikita Mehra

Department of Medical Oncology, Cancer Institute (WIA), Adyar

Andrew J. Cowan

Department of Medicine, University of Washington

S. Vincent Rajkumar

Division of Hematology, Mayo Clinic

Gurbakhash Kaur

Myeloma, Waldenstrom’s, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center